Literature DB >> 18607139

Endocrine causes of secondary hypertension.

Domenic A Sica1.   

Abstract

Secondary hypertension is common in clinical practice if a broad definition is applied. Various patterns of hypertension exist in the patient with an endocrine source of their disease, including new-onset hypertension in a previously normotensive individual, a loss of blood pressure control in a patient with previously well-controlled blood pressure, and/or labile blood pressure in the setting of either of these 2 patterns. A thorough history and physical exam, which can rule out concomitant medications, alcohol intake, and over-the-counter medication use, is an important prerequisite to the workup for endocrine causes of hypertension. Endocrine forms of secondary hypertension, such as pheochromocytoma and Cushing's disease, are extremely uncommon. Conversely, primary aldosteronism now occurs with sufficient frequency so as to be considered "top of the list" for secondary endocrine causes in otherwise difficult-to-treat or resistant hypertension. Primary aldosteronism can be insidious in its presentation since a supposed hallmark finding, hypokalemia, may be variable in its presentation. It is important to identify secondary causes of hypertension that are endocrine in nature because surgical intervention may result in correction or substantial improvement of the hypertension.

Entities:  

Mesh:

Year:  2008        PMID: 18607139      PMCID: PMC8110091          DOI: 10.1111/j.1751-7176.2008.08097.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  33 in total

Review 1.  Liquorice and its health implications.

Authors:  A Olukoga; D Donaldson
Journal:  J R Soc Promot Health       Date:  2000-06

Review 2.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

Review 3.  Clinical practice. The incidentally discovered adrenal mass.

Authors:  William F Young
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

4.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

Review 5.  The risks and benefits of aldosterone antagonists.

Authors:  Domenic A Sica
Journal:  Curr Heart Fail Rep       Date:  2005-08

Review 6.  Preoperative management of the pheochromocytoma patient.

Authors:  Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-11       Impact factor: 5.958

7.  Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.

Authors:  Cristiana Catena; GianLuca Colussi; Roberta Lapenna; Elisa Nadalini; Alessandra Chiuch; Pasquale Gianfagna; Leonardo A Sechi
Journal:  Hypertension       Date:  2007-09-24       Impact factor: 10.190

Review 8.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  Diagnostic management of benign and malignant pheochromocytoma.

Authors:  T Scholz; C Schulz; S Klose; H Lehnert
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-03       Impact factor: 2.949

Review 10.  Clonidine suppression test revisited.

Authors:  T Lenz; A Ross; P Schumm-Draeger; K L Schulte; H Geiger
Journal:  Blood Press       Date:  1998-05       Impact factor: 2.835

View more
  8 in total

1.  Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.

Authors:  Joachim H Ix; Christina L Wassel; Lesley A Stevens; Gerald J Beck; Marc Froissart; Gerjan Navis; Roger Rodby; Vicente E Torres; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

2.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

3.  Multimodality Imaging in Patients with Secondary Hypertension: With a Focus on Appropriate Imaging Approaches Depending on the Etiologies.

Authors:  Hyungwoo Ahn; Eun Ju Chun; Hak Jong Lee; Sung Il Hwang; Dong-Ju Choi; In-Ho Chae; Kyung Won Lee
Journal:  Korean J Radiol       Date:  2018-02-22       Impact factor: 3.500

4.  Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series.

Authors:  Jeongmin Lee; Jeonghoon Ha; Sang-Kuon Lee; Hye Lim Park; Sung-Hoon Kim; Dong-Jun Lim; Jung Min Lee; Sang-Ah Chang; Moo Il Kang; Min-Hee Kim
Journal:  Int J Gen Med       Date:  2021-03-01

5.  Relationship between kidney findings and systemic vascular damage in elderly hypertensive patients without overt cardiovascular disease.

Authors:  Giulio Geraci; Giuseppe Mulè; Gabriella Paladino; Marta Maria Zammuto; Antonella Castiglia; Emilia Scaduto; Federica Zotta; Calogero Geraci; Antonio Granata; Pasquale Mansueto; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-29       Impact factor: 3.738

6.  Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists.

Authors:  Keiichi Ikeda; Tsuyoshi Isaka; Kouki Fujioka; Yoshinobu Manome; Katsuyoshi Tojo
Journal:  Int J Endocrinol       Date:  2012-10-11       Impact factor: 3.257

7.  Association between hypertension and chronic arsenic exposure in drinking water: a cross-sectional study in Bangladesh.

Authors:  Mohammad Rafiqul Islam; Ismail Khan; John Attia; Sheikh Mohammad Nazmul Hassan; Mark McEvoy; Catherine D'Este; Syed Azim; Ayesha Akhter; Shahnaz Akter; Sheikh Mohammad Shahidullah; Abul Hasnat Milton
Journal:  Int J Environ Res Public Health       Date:  2012-12-07       Impact factor: 3.390

8.  Renal resistive index and aortic knob width relationship as a predictor of renal prognosis in essential hypertension.

Authors:  Nurhayat Ozkan Sevencan; Aysegul Ertinmaz Ozkan
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.